Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [2094]
News [6559]
Articles [135]
Editorials [5]
Conferences [171]
elearning [10]
ASCO 2015: Latest developments in prostate cancer treatment
Prof Cora Sternberg, Prof Noel Clarke, Prof Eleni Efstathiou, Prof Karim Fizazi
ASCO 2015: Latest developments in prostate cancer treatment ( Prof Cora Sternberg, Prof Noel Clarke, Prof Eleni Efstathiou, Prof Karim Fizazi )
31 May 2015
Raloxifene retained approximately 81% of the effectiveness of tamoxifen in...
Dr Lawrence Wickerham - NRG Oncology Research Group, Pittsburgh, USA
Raloxifene retained approximately 81% of the effectiveness of tamoxifen in preventing invasive breast cancer ( Dr Lawrence Wickerham - NRG Oncology Research Group, Pittsburgh, USA )
31 May 2015
Next generation inhibitors help overcome problems of resistance in ALK positive...
Dr Ross Camidge - University of Colorado, Denver, USA
Next generation inhibitors help overcome problems of resistance in ALK positive lung cancer ( Dr Ross Camidge - University of Colorado, Denver, USA )
31 May 2015
Transarterial chemoembolization with or without sorafenib for intermediate...
Prof Guohong Han - Xijing Hospital, Fourth Military Medical University, Xi'an...
Transarterial chemoembolization with or without sorafenib for intermediate-stage hepatocellular carcinoma ( Prof Guohong Han - Xijing Hospital, Fourth Military Medical University, Xi'an, China )
31 May 2015
Ibrutinib combination regimen shows substantial benefits in relapsed CLL
Dr Asher Chanan-Khan - Mayo Clinic, Jacksonville, USA
Ibrutinib combination regimen shows substantial benefits in relapsed CLL ( Dr Asher Chanan-Khan - Mayo Clinic, Jacksonville, USA )
30 May 2015
Eribulin extends overall survival for patients with advanced liposarcoma and...
Dr Patrick Schöffski - University Hospitals Leuven, Leuven, Belgium
Eribulin extends overall survival for patients with advanced liposarcoma and leiomyosarcoma ( Dr Patrick Schöffski - University Hospitals Leuven, Leuven, Belgium )
30 May 2015
Immunotherapy developments in lung, head and neck, liver and PD-1 repsonse...
Dr Lynn Schuchter - University of Pennsylvania, Philadelphia, USA
Immunotherapy developments in lung, head and neck, liver and PD-1 repsonse prediction ( Dr Lynn Schuchter - University of Pennsylvania, Philadelphia, USA )
29 May 2015
Pembrolizumab for head and neck cancer
Dr Tanguy Seiwert - University of Chicago, Chicago, USA
Pembrolizumab for head and neck cancer ( Dr Tanguy Seiwert - University of Chicago, Chicago, USA )
29 May 2015
Genomic marker predicts anti-PD-1 response in several cancers
Dr Dung Le - Johns Hopkins Kimmel Cancer Center, Baltimore, USA
Genomic marker predicts anti-PD-1 response in several cancers ( Dr Dung Le - Johns Hopkins Kimmel Cancer Center, Baltimore, USA )
29 May 2015
Pembrolizumab shows promising activity against head and neck cancer
Dr Tanguy Seiwert - University of Chicago, Chicago, USA
Pembrolizumab shows promising activity against head and neck cancer ( Dr Tanguy Seiwert - University of Chicago, Chicago, USA )
29 May 2015
Genomic marker predicts anti-PD-1 response in several cancers
Dr Dung Le - Johns Hopkins Kimmel Cancer Center, Baltimore, USA
Genomic marker predicts anti-PD-1 response in several cancers ( Dr Dung Le - Johns Hopkins Kimmel Cancer Center, Baltimore, USA )
29 May 2015
Prostate cancer and pharmacokinetics: Expert discussion
Prof Axel S. Merseburger and Prof Romano Danesi
Prostate cancer and pharmacokinetics: Expert discussion ( Prof Axel S. Merseburger and Prof Romano Danesi )
26 May 2015

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation